Genworth's Q3 Net Income Jumps 25% on Strong Revenue Growth
Ticker: GNW · Form: 10-Q · Filed: 2025-11-06T00:00:00.000Z
Sentiment: bullish
Topics: Insurance, Mortgage Insurance, Life Insurance, Share Repurchase, Financial Performance, Earnings Growth, Capital Management
Related Tickers: GNW, MTG, Radian
TL;DR
**Genworth's Q3 earnings beat expectations, and their aggressive share buyback program makes GNW a solid buy for value investors.**
AI Summary
Genworth Financial Inc. (GNW) reported a net income of $147 million for the three months ended September 30, 2025, an increase from $118 million in the prior-year period. Net income available to common stockholders rose to $116 million, or $0.29 per diluted share, compared to $85 million, or $0.19 per diluted share, in Q3 2024. Total revenues for the quarter increased to $1,935 million from $1,880 million year-over-year, driven by higher premiums of $886 million (up from $874 million) and net investment income of $799 million (up from $777 million). For the nine months ended September 30, 2025, net income available to common stockholders was $221 million, down from $300 million in the same period of 2024. The company repurchased 19,815,615 shares of common stock for $153 million during the nine months ended September 30, 2025, at an average price of $7.62 per share. A new share repurchase program of up to $350 million was authorized on September 18, 2025, with approximately $325 million remaining as of October 31, 2025, after repurchasing 3,302,403 shares in October 2025 at an average price of $8.76 per share.
Why It Matters
Genworth's improved Q3 net income and robust share repurchase activity signal a positive trend for investors, potentially boosting shareholder value and confidence. The company's continued focus on returning capital to shareholders, evidenced by the new $350 million repurchase program, could make GNW an attractive option in a competitive insurance market. For employees, stable financial performance often translates to job security and potential growth opportunities. Customers benefit from a financially healthy insurer, ensuring long-term policy stability. This performance positions Genworth more favorably against rivals like MGIC Investment Corporation and Radian Group Inc. in the mortgage insurance sector, and other life and annuity providers.
Risk Assessment
Risk Level: medium — While Genworth reported increased net income, the nine-month net income available to common stockholders decreased from $300 million in 2024 to $221 million in 2025, indicating some longer-term headwinds. Additionally, the company's accumulated other comprehensive income (loss) remains negative at $(1,395) million as of September 30, 2025, despite an improvement from $(1,642) million at December 31, 2024, suggesting ongoing volatility in certain financial instruments.
Analyst Insight
Investors should consider Genworth's consistent share repurchase strategy as a strong signal of management's confidence and commitment to shareholder returns. Given the positive Q3 performance and the new $350 million buyback authorization, GNW could be a compelling investment for those seeking capital appreciation and a company actively managing its share count.
Financial Highlights
- debt To Equity
- 0.16
- revenue
- $1,935M
- operating Margin
- N/A
- total Assets
- $88,486M
- total Debt
- $1,520M
- net Income
- $147M
- eps
- $0.29
- gross Margin
- N/A
- cash Position
- $2,036M
- revenue Growth
- +3.0%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Premiums | $886M | +1.4% |
| Net investment income | $799M | +2.8% |
| Net investment gains (losses) | $99M | +50.0% |
| Policy fees and other income | $151M | -7.4% |
Key Numbers
- $147M — Net Income (Q3 2025) (Increased from $118M in Q3 2024, a 24.6% rise.)
- $116M — Net Income Available to Common Stockholders (Q3 2025) (Increased from $85M in Q3 2024, a 36.5% rise.)
- $0.29 — Diluted EPS (Q3 2025) (Increased from $0.19 in Q3 2024.)
- $1,935M — Total Revenues (Q3 2025) (Increased from $1,880M in Q3 2024.)
- $153M — Share Repurchases (9 months ended Sep 30, 2025) (Repurchased 19,815,615 shares at an average price of $7.62.)
- $350M — New Share Repurchase Program (Authorized on September 18, 2025, demonstrating commitment to shareholder returns.)
- 399,380,567 — Common Stock Outstanding (As of October 31, 2025, reflecting impact of repurchases.)
- $221M — Net Income Available to Common Stockholders (9 months ended Sep 30, 2025) (Decreased from $300M in the same period of 2024.)
Key Players & Entities
- Genworth Financial, Inc. (company) — registrant
- Enact Holdings, Inc. (company) — mortgage insurance subsidiary
- CareScout (company) — aging care growth initiative
- Financial Accounting Standards Board (regulator) — issues accounting guidance
- New York Stock Exchange (regulator) — exchange where GNW is listed
- $147 million (dollar_amount) — net income for Q3 2025
- $116 million (dollar_amount) — net income available to common stockholders for Q3 2025
- $153 million (dollar_amount) — cost of share repurchases during nine months ended September 30, 2025
- $350 million (dollar_amount) — new share repurchase program authorization
- $325 million (dollar_amount) — remaining under new share repurchase program as of October 31, 2025
FAQ
What were Genworth Financial's key financial results for Q3 2025?
Genworth Financial reported a net income of $147 million for the three months ended September 30, 2025, an increase from $118 million in Q3 2024. Net income available to common stockholders was $116 million, or $0.29 per diluted share, compared to $85 million, or $0.19 per diluted share, in the prior year.
How did Genworth's revenues perform in the third quarter of 2025?
Total revenues for Genworth Financial increased to $1,935 million for the three months ended September 30, 2025, up from $1,880 million in the same period of 2024. This growth was primarily driven by premiums of $886 million and net investment income of $799 million.
What is Genworth Financial's strategy regarding share repurchases?
Genworth Financial is actively engaged in share repurchases. During the nine months ended September 30, 2025, the company repurchased 19,815,615 shares for $153 million. A new share repurchase program of up to $350 million was authorized on September 18, 2025, with approximately $325 million remaining as of October 31, 2025.
What are the main business segments of Genworth Financial?
Genworth Financial manages its business through three reportable segments: Enact, which offers private mortgage insurance; Long-Term Care Insurance, providing products in the United States; and Life and Annuities, servicing various protection and retirement income products.
Has Genworth Financial experienced any significant accounting changes recently?
In September 2025, the FASB issued new accounting guidance to refine the scope of derivative accounting and related to accounting for internal-use software costs. Genworth Financial is currently evaluating the impact of these changes, which are effective for the company on January 1, 2027.
What was the change in Genworth Financial's cash position?
Genworth Financial's cash, cash equivalents, and restricted cash decreased by $12 million during the nine months ended September 30, 2025, ending the period at $2,036 million, compared to $2,048 million at the beginning of the period.
How did Genworth's net income for the nine months ended September 30, 2025, compare to the prior year?
For the nine months ended September 30, 2025, Genworth Financial's net income available to common stockholders was $221 million, which is a decrease from $300 million reported for the same period in 2024.
What is the current status of Genworth Financial's common stock outstanding?
As of October 31, 2025, Genworth Financial had 399,380,567 shares of Common Stock, par value $0.001 per share, outstanding. This reflects the impact of ongoing share repurchase programs.
What are the primary risks Genworth Financial faces according to the filing?
The filing references Item 1A. Risk Factors, indicating that the company faces various risks. While specific details are not provided in the excerpt, these typically include market risk, interest rate risk, credit risk, and risks related to its insurance liabilities and regulatory environment.
How has Genworth Financial's total equity changed?
Genworth Financial's total equity increased to $9,821 million as of September 30, 2025, up from $9,431 million as of December 31, 2024. This increase was primarily driven by net income and other comprehensive income.
Risk Factors
- Investment Portfolio Volatility [medium — market]: The company holds $46.11 billion in fixed maturity securities and $6.315 billion in commercial mortgage loans. Fluctuations in interest rates and credit markets can negatively impact the value of these investments, as seen in the $99 million net investment gains for Q3 2025, which can be volatile.
- Interest Rate Sensitivity [medium — financial]: Genworth's financial performance is sensitive to changes in interest rates, which affect investment income and the valuation of liabilities. The company's net investment income was $799 million in Q3 2025, and changes in rates can impact future income and the fair value of its $55.36 billion in future policy benefits.
- Regulatory Changes [medium — regulatory]: The insurance industry is subject to extensive regulation. Changes in regulations related to capital requirements, product approvals, or consumer protection could increase compliance costs or restrict business operations.
- Operational and System Failures [low — operational]: The company relies on complex IT systems for policy administration, claims processing, and financial reporting. System failures or cybersecurity breaches could disrupt operations and lead to financial losses.
- Credit Risk [medium — financial]: The company is exposed to credit risk through its investment portfolio, particularly in commercial mortgage loans ($6.315 billion net) and reinsurance recoverables ($17.912 billion net). Deterioration in the credit quality of counterparties could lead to losses.
- Economic Downturns [high — market]: A significant economic downturn could lead to increased claims, reduced demand for insurance products, and further declines in investment values, impacting profitability.
Industry Context
Genworth Financial operates in the highly competitive life insurance and retirement solutions industry. Key trends include evolving customer needs for retirement income solutions, increasing regulatory scrutiny, and the impact of interest rate environments on investment income and product pricing. Competitors range from large diversified financial institutions to specialized annuity and life insurance providers.
Regulatory Implications
The insurance sector faces significant regulatory oversight concerning solvency, consumer protection, and market conduct. Genworth must navigate evolving capital requirements and compliance standards, which can impact operational costs and strategic flexibility. Changes in accounting standards or regulatory interpretations could also affect reported financial results.
What Investors Should Do
- [object Object]
- [object Object]
- [object Object]
- [object Object]
Key Dates
- 2025-09-30: Q3 2025 Earnings Release — Reported net income of $147 million and diluted EPS of $0.29, showing year-over-year improvement in quarterly performance.
- 2025-09-18: New Share Repurchase Program Authorized — Authorization of a $350 million program signals management's confidence and commitment to returning capital to shareholders.
- 2025-10-31: Share Repurchases in October 2025 — Company repurchased 3,302,403 shares for $28.7 million, indicating active execution of its capital return strategy.
- 2025-09-30: Balance Sheet Date — Total assets stood at $88.486 billion, with total liabilities at $78.665 billion, resulting in total equity of $9.821 billion.
- 2024-09-30: Q3 2024 Earnings Release — Provided a baseline for comparison, with Q3 2025 net income showing a significant increase.
Glossary
- Fixed maturity securities available-for-sale
- Investments in bonds and other debt instruments that the company intends to hold for an indefinite period but may sell in response to needs for liquidity or changes in interest rates. They are reported at fair value. (These represent a significant portion of Genworth's investment portfolio ($46.11 billion), impacting its financial performance and risk exposure.)
- Future policy benefits
- The estimated amount required to pay future benefits to policyholders under existing insurance policies. This is a major liability for insurance companies. (At $55.364 billion, this is the largest liability on Genworth's balance sheet, reflecting its core insurance business.)
- Accumulated other comprehensive income (loss)
- A component of equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and other items not included in net income. (A negative balance of ($1.395 billion) indicates accumulated unrealized losses, primarily from investment fluctuations.)
- Treasury stock
- Shares of the company's own stock that have been repurchased from the open market. It is recorded at cost and reduces total equity. (The company has repurchased a substantial number of shares (204.7 million as of Sep 30, 2025), reducing outstanding shares and increasing EPS.)
- Noncontrolling interests
- The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership interest of outside shareholders in consolidated subsidiaries. (Represents $1.009 billion of total equity, indicating significant ownership of subsidiaries by other parties.)
- Liability remeasurement (gains) losses
- Adjustments made to the carrying value of certain liabilities to reflect changes in actuarial assumptions or market conditions. These can result in gains or losses recognized in the income statement. (A $106 million gain in Q3 2025 indicates favorable adjustments to liabilities, boosting net income.)
Year-Over-Year Comparison
Compared to the prior year's third quarter, Genworth Financial Inc. demonstrated improved profitability with a 24.6% increase in net income to $147 million and a 36.5% rise in net income available to common stockholders to $116 million. Total revenues also saw a modest increase of 3.0% to $1,935 million, driven by higher premiums and net investment income. However, for the nine-month period, net income available to common stockholders declined from $300 million to $221 million, indicating some headwinds over the longer term. The company's balance sheet shows growth in total assets to $88.486 billion from $86.871 billion, while total liabilities also increased, leading to a slight rise in total equity.
Filing Stats: 4,802 words · 19 min read · ~16 pages · Grade level 14.5 · Accepted 2025-11-06 16:21:01
Key Financial Figures
- $0.001 — 0,567 shares of Common Stock, par value $0.001 per share, were outstanding. TABLE OF
Filing Documents
- gnw-20250930.htm (10-Q) — 7628KB
- gnw-exx311template.htm (EX-31.1) — 9KB
- gnw-exx312template.htm (EX-31.2) — 9KB
- gnw-exx321template.htm (EX-32.1) — 4KB
- gnw-exx322template.htm (EX-32.2) — 4KB
- gnw-20250930_g1.jpg (GRAPHIC) — 27KB
- 0001628280-25-050196.txt ( ) — 35685KB
- gnw-20250930.xsd (EX-101.SCH) — 116KB
- gnw-20250930_cal.xml (EX-101.CAL) — 185KB
- gnw-20250930_def.xml (EX-101.DEF) — 718KB
- gnw-20250930_lab.xml (EX-101.LAB) — 1326KB
- gnw-20250930_pre.xml (EX-101.PRE) — 1081KB
- gnw-20250930_htm.xml (XML) — 10437KB
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements 3 Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 3 Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 202 4 (Unaudited) 4 Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 202 4 (Unaudited) 5 Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2025 and 202 4 (Unaudited) 6 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 202 4 (Unaudited) 8 Notes to Condensed Consolidated Financial Statements (Unaudited) 9 Note 1 — Business and Basis of Presentation 9 Note 2 — Accounting Changes 10 Note 3 — Earnings (Loss) Per Share 11 Note 4 — Investments 12 Note 5 — Derivative Instruments 28 Note 6 — Fair Value of Financial Instruments 34 Note 7 — Deferred Acquisition Costs 55 Note 8 — Future Policy Benefits 56 Note 9 — Policyholder Account Balances 61 Note 10 — Additional Insurance Liabilities 64 Note 11 — Market Risk Benefits 65 Note 12 — Separate Accounts 68 Note 13 — Liability for Policy and Contract Claims 68 Note 14 — Income Taxes 70 Note 15 — Segment Information 71 Note 16 — Commitments and Contingencies 74 Note 17 — Changes in Accumulated Other Comprehensive Income (Loss) 79
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 82
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 128
Controls and Procedures
Item 4. Controls and Procedures 128
—OTHER INFORMATION
PART II—OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 130
Risk Factors
Item 1A. Risk Factors 130
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 130
Other Information
Item 5. Other Information 130
Exhibits
Item 6. Exhibits 131
Signatures
Signatures 132 2 Table of Contents
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION Item1. Financial Statements GENWORTH FINANCIAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in millions, except par value and share amounts) September 30, 2025 December 31, 2024 (Unaudited) Assets Investments: Fixed maturity securities available-for-sale, at fair value (amortized cost of $ 48,379 and $ 48,720 , respectively, and allowance for credit losses of $ 28 and $ 10 , respectively) $ 46,110 $ 44,902 Equity securities, at fair value 546 515 Commercial mortgage loans 6,374 6,450 Less: Allowance for credit losses ( 59 ) ( 39 ) Commercial mortgage loans, net 6,315 6,411 Policy loans 2,311 2,310 Limited partnerships 3,473 3,142 Other invested assets 658 648 Total investments 59,413 57,928 Cash, cash equivalents and restricted cash 2,036 2,048 Accrued investment income 589 607 Deferred acquisition costs 1,632 1,779 Intangible assets 184 197 Reinsurance recoverable 17,935 17,679 Less: Allowance for credit losses ( 23 ) ( 24 ) Reinsurance recoverable, net 17,912 17,655 Other assets 421 444 Deferred tax asset 1,788 1,718 Market risk benefit assets 62 57 Separate account assets 4,449 4,438 Total assets $ 88,486 $ 86,871 Liabilities and equity Liabilities: Future policy benefits $ 55,364 $ 53,610 Policyholder account balances 14,039 14,594 Market risk benefit liabilities 429 465 Liability for policy and contract claims 710 670 Unearned premiums 96 115 Other liabilities 2,056 2,026 Long-term borrowings 1,520 1,518 Separate account liabilities 4,449 4,438 Liabilities related to discontinued operations 2 4 Total liabilities 78,665 77,440 Commitments and contingencies (Note 16) Equity: Common stock, $ 0.001 par value; 1,500,000,000 shares authorized; 607,393,280 and 606,314,179 shares issued, respectively; 402,682,970 and 421,419,484 shares outstanding, respectively 1 1 Additional paid-in capital 11,879 11,875 Accumulated other comprehensive income (loss) ( 1,395 ) ( 1,642 ) Retained ea